Effect of 2α-Hydroxyursolic acid on NF-κB activation induced by TNF-α in human breast cancer MCF-7 cells

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 18, 2008, Pages 8412-8417

  Yoon, Hyungeun ^a   Liu, Rui Hai ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

2a hydroxyursolic acid; Apples; Breast cancer; MCF 7 cells; Phytochemicals

Indexed keywords

MALUS X DOMESTICA;

2 HYDROXYURSOLIC ACID; 2-HYDROXYURSOLIC ACID; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRITERPENE; TUMOR NECROSIS FACTOR ALPHA;

APPLE; ARTICLE; BREAST TUMOR; CELL DIVISION; CHEMISTRY; DRUG EFFECT; FRUIT; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; FRUIT; HUMANS; MALUS; NF-KAPPA B; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53649106673     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8012844     Document Type: Article

References (54)

1. Doll, R.; Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 1981, 66, 1191-1308.
2. Willett, W. C. Diet and health: what should we eat? Science 1994, 264, 532-537.
3. Willett, W. C. Balancing life-style and genomics research for disease prevention. Science 2002, 296, 695-698.
4. Block, G.; Patterson, B.; Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1-29.
5. Liu, R. H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134, 3479S-3485S.
6. Liu, R. H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 2003, 78, 517S-520S.
7. American Cancer Society. Cancer Facts and Figures 2007; American Cancer Society: Atlanta, GA, 2007.
8. Caldas, C; Aparicio, A. J. The molecular outlook. Nature 2002, 415, 484-485.
9. Bours, V.; Bentires-Ali, M.; Hellin, A.; Viatour, P.; Robe, P.; Delhalle, S.; Benoit, V.; Merville, M. Nuclear factor-κB, cancer, and apoptosis. Biochem. Pharmacol. 2000, 60, 1085-1090.
10. Sun, Z.; Andersson, R. NF-κB activation and inhibition: a review. SHOCK 2002, 18, 99-106.
11. Van Waes, C. Nuclear factor-κB in development, prevention, and therapy of cancer. Clin. Cancer Res. 2007, 13, 1076-1082.
12. Nakshatri, H.; Goulet, R. J., Jr. NF-κB and breast cancer. Curr. Probl. Cancer 2002, 26, 282-309.
13. Ames, B. N.; Gold, L. S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res. 1991, 250, 3-16.
14. Liu, R. H.; Hotchkiss, J. H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 1995, 73, 89.
15. Sun, J.; Chu, Y.; Wu, X.; Liu, R. H. Antioxidant and antiproliferative activities of common fruits. J. Agric. Food Chem. 2002, 50, 7449-7454.
16. Boyer, J.; Liu, R. H. Apple phytochemicals and their health benefits. Nutr. J. 2004, 3, 5.
17. Knekt, P.; Järvinen, R.; Seppänen, R.; Heliövaara, M.; Teppo, L.; Pukkala, E.; Aromaa, A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 1997, 146, 223-230.
18. Le Marchand, L.; Murphy, S. P.; Hankin, J. H.; Wilkens, L. R.; Kolonel, L. N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 2000, 92, 154-160.
19. Feskanich, D.; Ziegler, R. G.; Michaud, D. S.; Giovannucci, E. L.; Speizer, F. E.; Willett, W. C; Colditz, G. A. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J. Natl. Cancer Inst. 2000, 92, 1812-1823.
20. Knekt, P.; Järvinen, R.; Reunanen, A.; Maatela, J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 1996, 312, 478-481.
21. Tabak, C.; Arts, I. C. W.; Smit, H. A.; Heederik, D.; Kromhout, D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavonones. Am. J. Respir. Crit. Care Med. 2001, 164, 61-64.
22. Knekt, P.; Kumpulainen, J.; Järvinen, R.; Rissanen, H.; Heliövaara, M; Reunanen, A.; Hakulinen. T.; Aromaa, A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76, 560-568.
23. Eberhardt, M. V.; Lee, C. Y.; Liu, R. H. Antioxidant activity of fresh apples. Nature 2000, 405, 903-904.
24. Liu, R. H.; Sun, J. Antiproliferative activity of apples is not due to phenolic-induced hydrogen peroxide formation. J. Agric. Food Chem. 2003, 51, 1718-1723.
25. Yoon, H.; Liu, R. H. Effect of selected phytochemicals and apple extracts on NF-κB activation in human breast cancer MCF-7 cells. J. Agric. Food Chem. 2007, 55, 3167-3173.
26. Liu, R. H.; Liu, J.; Chen, B. Apples prevent mammary tumors in rats. J. Agric. Food Chem. 2005, 53, 2341-2343.
27. Wolfe, K.; Wu, X.; Liu, R. H. Antioxidant activity of apple peels. J. Agric. Food Chem. 2003, 51, 609-614.
28. Natarajan, K.; Manna, S. K.; Chaturvedi, M. M.; Aggarwal, B. B. Protein tyrosine kinase inhibitors block tumor necrosis factorinduced activation of nuclear factor-κB, degradation of IκBα, nuclear translocation of p65, and subsequent gene expression. Arch. Biochem. Biophys. 1998, 352, 59-70.
29. Manna, S. K.; Mukhopadhyay, A.; Aggarwal, B. B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000, 164, 6509-6519.
30. Pozo-Guisado, E.; Merino, J. M.; Mulero-Navarro, S.; Lorenzo-Benayas, M. J.; Centeno, F.; Alvarez-Barrientos, A.; Salguero, P. M. F. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-κB. Int. J. Cancer 2005, 115, 74-84.
31. Aggarwal, B. B.; Shishodia, S.; Takada, Y.; Banerjee, S.; Newman, R. A.; Bueso-Ramos, C. E.; Price, J. E. Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005, 11, 7490-7498.
32. Shishodia, S.; Amin, H. M.; Lai, R.; Aggarwal, B. B. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces Gl/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 2005, 70, 700-713.
33. Yang, F.; Oz, H. S.; Barve, S.; De Villiers, W. J. S.; McClain, C. J.; Varilek, G. W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-κB activation by inhibiting IκB kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 2001, 60, 528-533.
34. Gupta, S.; Hastak, K.; Afaq, F.; Ahmad, N.; Mukhtar, H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor κB and induction of apoptosis. Oncogene 2004, 23, 2507-2522.
35. Syed, D. N; Kweon, M.-H.; Hardi, N.; Bhatia, N.; Spiegelman, V. S.; Mukhtar, H. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells. Oncogene 2007, 26, 673-682.
36. Shishodia, S.; Majumdar, S.; Banerjee, S.; Aggarwal, B. B. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin Dl. Cancer Res. 2003, 63, 4375-4383.
37. He, X.; Liu, R. H. Triterpenoids Isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J. Agric. Food Chem. 2007, 55, 4366-4370.
38. Sun, J.; Liu, R. H. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006, 241, 124-134.
39. Wolfe, K. L.; Liu, R. H. Apple peels as a value-added food ingredient. J. Agric. Food Chem. 2003, 51, 1676-1683.
40. Janssen, Y. M. W.; Sen, C. K. Nuclear factor κB activity in response to oxidants and antioxidants. Methods Enzymol. 1999, 300, 363-374.
41. Nakajima, H.; Nagaso, H.; Kakui, N.; Ishikawa, M.; Hiranuma, T.; Hoshiko, S. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-κB-dependent gene expres sion in primary cultured mouse glial cells. J. Biol. Chem. 2004, 279, 42774-42786.
42. Liu, R. H.; Jacob, J.; Tennant, B. Chemiluminescent detection of protein molecular weight markers in western blot techniques. Biotechniques 1997, 22, 594-595.
43. Oliver, M.; Harrison, N. K.; Bishop, J. E.; Cole, P. J.; Laurent, G. J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 1989, 92, 513-518.
44. Wolfe, K. L.; Liu, R. H. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J. Agric. Food Chem. 2007, 55, 8896-8907.
45. Place, R. F.; Noonan, E. J.; Giardina, C. HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: downregulation of proteasome subunit expression stabilizes IκBα. Biochem. Pharmacol. 2005, 70, 394-406.
46. Viatour, P.; Merville, M.; Bours, V.; Chariot, A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30, 43-52.
47. Maniatis, T. A ubiquitin ligase complex essential for the NF-κB, Wnt/wingless, and hedgehog signaling pathways. Genes Dev. 1999, 13, 505-510.
48. Kane, R. C; Farell, A. T.; Sridhara, R.; Pazdur, R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin. Cancer Res. 2006, 12, 2955-2960.
49. Wu, J. T.; Kral, J. G. The NF-κB/IκB signaling system: a molecular target in breast cancer therapy. J Surg. Res. 2005, 123, 158-169.
50. Guttridge, D. C.; Albanese, C.; Reuther, J.; Pestell, R. G.; Baldwin, A. S., Jr. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin Dl. Mol. Cell. Biol. 1999, 19, 5785-5799.
51. Lee, H. H.; Dadgostar, H.; Cheng, Q.; Shu, J.; Cheng, G. NF-κB-mediated up-regulation of Bcl-x and Bfl-l/Al is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9136-9141.
52. Viatour, P.; Bentires-Alj, M.; Chariot, A.; Deregowski, V.; De Leval, L.; Merville, M.; Bours, V. NF-κB2/p100 induces Bcl-2 expression. Leukemia 2003, 17, 1349-1356.
53. Tergaonkar, V.; Pando, M.; Vafa, O.; Wahl, G.; Verma, I. p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 2002, 1, 493-503.
54. Thornberry, N. A.; Lazebnik, Y. Caspases: enemies within. Science 1998, 281, 1312-1316.